UAE Addiction Therapeutics Market Report 2022 to 2030

UAE Addiction Therapeutics Market Analysis

$ 3999

UAE addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $93 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The rise in mental health awareness and awareness about addiction treatments through government encouragement and support has increased investments in addiction therapeutics infrastructure which has in turn reduced the social stigma associated with it. These changes in environment have led to an increase in the addiction treatment drug market in the UAE. Some major key players in UAE addiction therapeutics are Viatris, Sahara Pharmaceutical, AbbVie, Pfizer, Indivior, Reckitt Benckiser Pharmaceuticals, Mundipharma, Teva Pharmaceutical, Alkermes and Hikma

ID: IN10AEPH424 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE

Buy Now

UAE Addiction Therapeutics Market Executive Summary

UAE addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $93 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period.

Addiction treatment refers to a wide range of treatment options for those battling with addiction issues or substance abuse disorders under the blanket of addiction treatment. It seeks to treat the underlying causes and effects of addiction, assist individuals in achieving long-term recovery, and enhance their general wellbeing. The discomfort that comes with the physical and mental aspects of stopping addictive substances is lessened by medications and supportive care. Addiction frequently coexists with mental illnesses like anxiety or depression. There is a significant demand and supply for narcotic drugs in the UAE, despite the harsh penalties for those who produce, export, transport, buy, sell, and store them. As of 2021, 8428 people were detained in the UAE for drug-related crimes, up 20.8% from 6973 in 2020.

A variety of innovative therapies and support services for those struggling with addiction have been introduced in the UAE. New programs that enable addiction patients to communicate with medical teams virtually were disclosed by the National Rehabilitation Centre (NRC). Additionally, to improve access to addiction treatment treatments and support in the United Arab Emirates, the NRC has implemented support groups that make use of visual communication technology. These groups provide patients and their families with remote technical resources and assistance.

Considerable research is being conducted at Sharjah University to investigate the possibility of herbal treatments and traditional medicinal practices as additional approaches to addiction treatment, especially in conjunction with contemporary therapies.

Market Dynamics

Market Growth Drivers

Government Support and Investment: The UAE government is actively funding research and treatment programs because it acknowledges the burden that addiction causes. This involves joint ventures with global organizations to create best practices and programs, such as the National Rehabilitation Program.

Growing Awareness: Growing public awareness of mental health issues, including substance use disorders, and government-led programs that support addiction treatment and mental health education are extensively raising the market for addiction therapeutics. These initiatives are increasing the need for addiction therapeutics by reducing the stigma related to addiction and motivating more people to get treatment.

Developments in Treatment Modalities: Ongoing improvements in addiction therapies, such as novel drugs, behavioural therapy, and technology-based interventions, lead to increased treatment effectiveness. Better treatment options will encourage more healthcare professionals and patients to adopt these innovative strategies.

Market Restraints

Cultural Factors: Cultural nuances and perspectives on mental health and addiction may make it difficult to apply successful interventions and treatments, requiring specialized methods to handle cultural sensitivity.

Regulatory Constraints: Strict laws and regulations pertaining to particular addiction therapies or treatments may restrict the usage or availability of particular drugs or therapy modalities in the United Arab Emirates, which may have an influence on patient treatment options.

Workforce Shortages and Training: The availability of addiction treatment services may be hampered by a shortage of mental health specialists, such as addiction counsellors, psychologists, therapists, and psychiatrists. Ensuring that the workforce has the necessary skills in evidence-based addiction therapies could also be difficult. These variables may have an impact on the expansion and development of the market for addiction therapies.

Notable Recent Updates

Jan 2022, Pfizer, Inc. announced a new strategic alliance with Alex Therapeutics to use the latter's Al-based platform to deliver Cognitive Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT) to patients suffering from nicotine addiction while also personalizing treatment through digital therapeutics.

Healthcare Policies and Regulatory Landscape

National Rehabilitation Centre (NRC): By providing treatment programs, support services, and rehabilitation initiatives, the UAE's National Rehabilitation Centre plays a crucial role in tackling addiction and substance use disorders. Enhancing addiction therapies and offering all-encompassing care to those struggling with substance misuse are its goals.

Ministry of Health and Prevention (MOHAP): MOHAP, is crucial to the regulation of medicines, particularly medications used as addiction treatments. Before pharmaceutical items are distributed in the United Arab Emirates, it supervises the licensing, approval, and registration procedures. MOHAP sets strict guidelines for the manufacture, import, export, distribution, and use of pharmaceuticals in order to conform to global standards for quality and safety. Furthermore, MOHAP oversees and approves clinical trials of pharmaceutical goods, including those for treatments for addiction, making sure that they comply with legal requirements and ethical standards in the United Arab Emirates.

Emirates Authority for Standardization and Metrology (ESMA): Pharmaceuticals is one of the several businesses that ESMA regulates and upholds standards for. Its functions include creating specifications that guarantee pharmaceutical products satisfy global benchmarks for efficacy, safety, and quality. Ensuring that established quality standards are followed during the production, importation, distribution, and use phases.

Drug Control Department: It is a part of the Ministry of Health and Prevention (MOHAP). It oversees activities like enforcing compliance with rules and regulations regarding medications, particularly addiction therapies, through regulatory enforcement. Procedures for licensing, inspections, and the implementation of corrective measures to ensure compliance.

Competitive Landscape

Key Players

Viatris
Sahara Pharmaceutical
AbbVie
Pfizer
Indivior
Reckitt Benckiser Pharmaceuticals
Mundipharma
Teva Pharmaceutical
Alkermes
Hikma

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.